Table 1 KCNH gene variants identified in patients with CHD

From: Membrane potential drives the exit from pluripotency and cell fate commitment via calcium and mTOR

Blinded ID

Gene

Phenotype

Allele type

Class

AA change

1-09347

KCNH1

CTD/Htx

LOF het

splice

.

1-01004

KCNH1

CTD/Htx

LOF het

frameshift_deletion

p.G149fs

1-05070

KCNH3

LVO

LOF het

stopgain

p.R139X

1-07611

KCNH3

CTD

CmpHet

misD/misD

A911V/ S1021P

1-01856

KCNH3

LVO

CmpHet

misD misD

A357T/ F542L

1-05499

KCNH3

CTD

de novo

misD

p.E859D

1-02696

KCNH5

Htx/TGA

de novo

misD

p.N817S

1-05146

KCNH6

Htx

LOF het

stopgain

p.S858X

1-07078

KCNH6

CTD

LOF het

stopgain

p.E587X

1-02620

KCNH6

other

LOF het

stopgain

p.Q487X

1-06077

KCNH6

Htx

LOF het

frameshift_insertion

p.S671fs

1-02515

KCNH6

Htx

de novo

misD

p.T274M

1-01783

KCNH7

LVO

LOF het

stopgain

p.Y1162X

1-12888

KCNH7

CTD

LOF het

stopgain

p.E944X

1-06600

KCNH8

Htx/TGA

LOF het

frameshift_deletion

p.D782fs

1-06579

KCNH8

other

LOF het

stopgain

p.E576X

  1. CTD conotruncal defect, Htx heterotaxy, LVO left ventricular outflow tract obstruction, TGA transposition of the great arteries, LOF loss of function, CmpHet compound heterozygote, misD damaging missense mutation according to previously published criteria.